Current Management of the Neonatal Abstinence Syndrome: A Critical Analysis of the Evidence

Neonatology

Volumn 71, Issue 6, 1997, Pages 345-356

  Theis, Jochen G W ^a   Selby, Peter ^b   Ikizler, Yazemir ^b   Koren, Gideon ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Chlorpromazine; Diazepam; Neonatal abstinence syndrome; Paregoric; Phenobarbital; Review; Study design

Indexed keywords

CHLORPROMAZINE; CLONIDINE; DIAZEPAM; METHADONE; MORPHINE; OPIATE; PAREGORIC; PHENOBARBITAL;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; META ANALYSIS; NEWBORN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; CHLORPROMAZINE; CLINICAL TRIALS; CLONIDINE; DIAZEPAM; DRUG THERAPY, COMBINATION; HUMANS; HYPNOTICS AND SEDATIVES; INFANT, NEWBORN; MEDLINE; METHADONE; MORPHINE; NEONATAL ABSTINENCE SYNDROME; OPIUM; PARASYMPATHOLYTICS; PHENOBARBITAL; SYMPATHOLYTICS;

DRYOBALANOPS;

EID: 0030954379     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000244435     Document Type: Article

References (57)

1. Dicker M, Leighton EA: Trends in the US prevalence of drug-using parturient women and drug-affected newborns, 1979 through 1990, Am J Publ Health 1994;84:1433-1438.
2. Stimmel B, Goldberg J, Rcisman A, Murphy RJ, Teets K: Fetal outcome in narcotic-dependent women: The importance of the type of maternal narcotic used, Am J Drug Alcohol Abuse 1982—83;9:383-395.
3. Zelson C, Kahn EJ, Neumann L, Folk G: Heroin withdrawal syndrome, J Pediatr 1970:76:483-484.
4. Doberczak TM, Kandall SR, Friedmann P: Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal, Obstet Gynecol 1993:81:936-940.
5. Newman RG, Bashkow S, Calko D: Results of 313 consccutivc live births of infants delivered to patients in the New York City Methadone Maintenance Treatment Program, Am J Obstet Gynecol 1975: 121:233-237.
6. Mangurten HH, Bcnawra R: Neonatal codeine withdrawal in infants of nonaddicted mothers, Pediatrics 1980:65:159-160.
7. Van Lecuwcn G, Guthrie R, Stange F: Narcotic withdrawal reaction in a newborn infant due to codeine, Pediatrics 1965;36:635-636.
8. Blumenthal I, Lindsay S: Neonatal barbiturate withdrawal, Postgrad Med J 1977:53:157-158.
9. Coles CD, Smith IE: Neonatal ethanol withdrawal: Characteristics in clinically normal, nondysmorphic neonates, J Pediatr 1984; 105:445-451.
10. Robe LB, Gromisch DS, Iosub S: Symptoms of neonatal ethanol withdrawal, Curr Alcohol 1981:8:485-493.
11. Auerbach JG, Hans SL, Marcus J, Maeir S: Maternal psychotropic medication and neonatal behavior, Ncurotoxicol Tcratol 1992; 14:399-406.
12. Levy M, Spino M: Neonatal withdrawal syndrome: Associated drugs and pharmacologic management, Pharmacotherapy 1993; 13: 202-211.
13. Finnegan LP: Treatment issues for opioid-dependent women during the perinatal period, J Psychoactive Drugs 1991;23:191-201.
14. Finnegan LP: Report of the Expert Advisory Committee on the use of drugs in the treatment of abuse and dependence to narcotic and controlled drugs, Can Med Assoc J 1990; 143:861-865.
15. Connaughton JF, Reeser D, Schut J, Finnegan LP: Perinatal addiction: Outcome and management, Am J Obstct Gynecol 1977;129:679-686.
16. Zelson C, Lee SJ, Casalino M: Neonatal narcotic addiction, Comparative effects of maternal intake of heroin and methadone, N Engl J Med 1973;289:1216-1220.
17. Harper RG, Solish G, Feingold E, Gersten-Woolf NB, Sokal MM: Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome, Am J Obstet Gynecol 1977;129:417-424.
18. Finnegan LP, Kaltenbach K: Neonatal abstinence syndrome; in Hoe-kclnian RA, Friedman SB, Nelson NM, Seidel MM: Primary' Pediatric Care, ed 2, St, Louis, Mosby Year Book, 1992, pp 1367-1378.
19. Desmond MM, Wilson GS: Neonatal abstinence syndrome, Recognition and diagnosis, Addict Dis 1975: 2:113-121.
20. Desmond M, Schwaneckc R, Wilson G, Yasunaga S, Burgdorff 1: Maternal barbiturate utilization and neonatal withdrawal symptomatology, J Paediatr 1972:80:190-197.
21. Blinick G, Wallach R, Jerez E, Ackermann G: Drug addiction in pregnancy and in the neonate, Am J Obstet Gynecol 1976;125:135-142.
22. Sutton LR, Hindcrliter SA: Diazepam abuse in pregnant women on methadone maintenance, Implications for the neonate, Clin Pediatr 1990;29:108-111.
23. Kaltenbach K, Finnegan LP: Neonatal abstinence syndrome, pharmacotherapy and developmental outcome, Ncurobehav Toxicol Teratol 1986:8:353-355.
24. Franck L, Vilardi J: Assessment and management of opioid withdrawal in ill neonates, Neonatal Network 1995;14:39-48.
25. Kron RE, in round table discussion of Zelson C: Acute management of neonatal addiction, Addict Dis 1975;2:159-168.
26. Wijburg FA, deKleine MJ, Flcury P, Soepatmi S: Morphine as an antiepileptic drug in neonatal abstinence syndrome, Acta Paediatr Scand 1991;80:875-877.
27. Pacifico P, Nardelli E, Pamarotto MF: Neonatal heroin withdrawal syndrome: Evaluation of different pharmacological treatments, Pharmacol Res 1989;21(suppl l):63-64.
28. Hoder EL, Leckman JF: Clonidine treatment of neonatal narcotic abstinence syndrome, Psychiatry Res 1984:13:243-251.
29. Kandall SR, Doberczak TM, Maucr KR, Strashum RH, Korts DC: Opiate v CNS depressant therapy in neonatal drug abstinence syndrome, Am J Dis Child 1983;137:378-382.
30. Finnegan LP, Mitros TF, Hopkins LE: Management of neonatal narcotic abstinence utilizing a phénobarbital loading dose method, NIDA Res Monogr 1979:27:247-253.
31. Herzlinger RA, Kandall SR, Vaughan HG Jr: Neonatal seizures associated with narcotic withdrawal, J Pediatr 1977:91:638-641.
32. Madden JD, Chappel JN, Zuspan F, Gumpel J, Mejia A, Davis R: Observation and treatment of neonatal narcotic withdrawal, Am J Obstet Gynccol 1977:127:199-201.
33. Rosen M: Use of diazepam in neonatal narcotic withdrawal syndrome, Pediatrics 1972;49:314.
34. Nathenson G, Golden GS, Litt IF: Diazepam in the management of the neonatal narcotic withdrawal syndrome, Pediatrics 1971:48:523-527.
35. Kahn EJ, Neumann LL, Polk GA: The course of the heroin withdrawal syndrome in newborn infants treated with phénobarbital or chlor-promazine, J Pediatr 1969,75:495-500.
36. Evidence-Based Medicine Working Group: Evidence-based medicine, JAMA 1992;268:2420-2425.
37. Medical Subject Headings - Annotated Alphabetic List 1995, Bethes-da, National Library of Medicine, 1994.
38. Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP: Neonatal abstinence syndrome: Assessment and management, Addict Dis I975;2: 141-158.
39. Finnegan LP, Kron RE, Connaughton JF Jr, Emich JP: Assessment and treatment of abstinence in the infant of the drug-dependent mother, Int J Clin Pharmacol 1975:12: 19-32.
40. Kron RE, Litt M, Finnegan L.P: Narcotic addiction in the newborn: Differences in behavior generated by methadone and heroin, Int J Clin Pharmacol 1975;12:63-69.
41. Kron RE, Litt M, Eng D, Phoenix MD, Finnegan LP: Neonatal narcotic abstinence: Effects of pharmaco-therapeutic agents and maternal drug usage on nutritive sucking behavior, J Pediatr 1976;88:637-641.
42. Finnegan LP, Michael H: An evaluation of neonatal abstinence treatment modalities, NIDA Res Monogr 1984:49:282-288.
43. Carin I, Glass L, Parckh A, Solomon N, Steigman J, Wong S: Neonatal methadone withdrawal, Effect of two treatment regimens, Am J Dis Child 1983; 137:1166-1169.
44. Finnegan LP, Ehrlich SM: Maternal drug abuse during pregnancy: Evaluation and pharmacotherapy for neonatal abstinence; in Adler MW, Cowan A (eds): Modem Methods in Pharmacology, New York, Wiley-Liss, 1990, vol 6: Testing and Evaluation of Drugs of Abuse, pp 255-263.
45. Kandall SR, Albin S, Gartner LM, Lee KS, Hidclman A, Lowinson J: The narcotic-dependent mother: Fetal and neonatal consequences, Early Hum Dev 1977:1:159-169.
46. Osol A, Hoover E (cds): Remington's Pharmaceutical Sciences, ed 15, Easton, Mack, 1975, p 1037.
47. Jaffe JH, Martin WR: Opioid analgesics and antagonists; in Gilman AG, Goodman LS, Rail TW, Murad F (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics, ed 7, New York, Macmillan, 1985, pp 491-531.
48. Lam SK, To WK: Neonatal narcotic withdrawal in Hong Kong Chinese, Asia- Oceania J Obstet Gynecol 1994;20:231-236.
49. Dahlem P, Bucher HU, Ursprung T, Mieth D, Gautschi K: Nachweis von Drogen im Mekonium, Monatsschr Kinderheilkd 1992:140:354-356.
50. Areas Cruz R, Figueras Aloy J, Vi-vanova Juanola JM, Comas Mas-mitja L, Jimenez Gonzalez R, Cruz Hernandez M: Recicn nacido de madre adicta a las drogas: aspectos materno perinatologicos, neonatales y sindrome de abstincncia, An Esp Pediatr 1991;34:123-127.
51. Kaltcnbach KA: Effects of in-utero opiate exposure: New paradigms for old questions, Drug Alcohol Depend 1994:36:83-87.
52. Konkol RJ, Murphcy LJ, Fcrricro DM, Dempsey DA, Olsen GD: Cocaine metabolites in the neonate: Potential for toxicity, J Child Neurol 1994:9:242-248.
53. Fulroth R, Philips B: Perinatal outcome of infants exposed to cocaine and/or heroin in utero, A J Dis Child 1989;143:905-910.
54. Koren G, Klein J, Forman R, Graham K, Phan MK: Biological markers of intrauterine exposure to cocaine and cigarette smoking, Dev Pharmacol Ther 1992;18:228-236.
55. Chasnoff IJ, Burns WJ: The Moro reaction: A scoring system for neonatal narcotic withdrawal, Dev Med Child Neurol 1984;26:484-489.
56. Green M, Suffct F: The Neonatal Narcotic Withdrawal Index: A device for the improvement of care in the abstinence syndrome, Am J Drug Alcohol Abuse 1981:8:203-213.
57. Lipsitz PJ: A proposed narcotic withdrawal score for use with new-boni infants, A pragmatic evaluation of its efficacy, Clin Pediatr 1975:14:592-594.